INS and type 1 diabetes mellitus: Similarly, Sharma et al. [181] showed that cholecalciferol at a single monthly dose of 60,000 IU in addition to insulin therapy (intervention group) for six months did not lead to any significant difference in HbA1c and mean insulin requirements compared to insulin therapy alone (control group) in children with established T1D.